Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001 -   Novel compound for targeted tumor therapy to be evaluated in patients with soft tissue sarcoma-   First patients to be enrolled in Q2, 2023 Munich, Germany – March 28, 2023 – Thermosome, a...

Leonhardt Ventures Announces Issuance of Pioneering U.S. Patent for Multi-Modality Customized Bioelectric Treatment of Cancer Mission Viejo, California, United States, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC, a pioneer in developing bioelectric and biologic innovations for organ regeneration and healing,...